RELY (Remitly Global, Inc. Common Stock) Stock Analysis - News
Remitly Global, Inc. Common Stock (RELY) is a publicly traded Technology sector company. As of May 21, 2026, RELY trades at $21.53 with a market cap of $4.51B and a P/E ratio of 43.15. RELY moved +3.40% today. Year to date, RELY is +64.61%; over the trailing twelve months it is -5.35%. Its 52-week range spans $12.08 to $27.32. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces RELY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in RELY news today?
Remitly Global to Join S&P SmallCap 600 on May 14, 2026: Remitly Global will be added to the S&P SmallCap 600 index effective May 14, 2026, replacing Apellis Pharmaceuticals, which is set to be acquired by Biogen. Inclusion in the index often triggers increased institutional demand and greater share liquidity, potentially supporting a near-term boost in the company’s valuation.
Remitly Global to Join S&P SmallCap 600 on May 14, 2026: Remitly Global will be added to the S&P SmallCap 600 index effective May 14, 2026, replacing Apellis Pharmaceuticals, which is set to be acquired by Biogen. Inclusion in the index often triggers increased institutional demand and greater share liquidity, potentially supporting a near-term boost in the company’s valuation.
Does Rallies summarize RELY news?
Yes. Rallies summarizes RELY news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is RELY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RELY. It does not provide personalized investment advice.
